The diagnostic value of <scp>MRI</scp> for persistent prostate cancer following irreversible electroporation focal therapy
Favourable specificity but poor sensitivity was achieved with use of MRI to detect persistent clinically significant prostate cancer after IRE treatment. Repeat TMB should not be deferred, regardless of MRI results.
Authors
- Theo M. de Reijke (ORCID: https://orcid.org/0000-0003-0651-7361)
- M. Pilar Laguna Pes (ORCID: https://orcid.org/0000-0003-0906-4417)
- Paula Pelechano Gómez
- Gordon Muir (ORCID: https://orcid.org/0000-0003-2248-0749)
- Chi‐Ho Leung (ORCID: https://orcid.org/0000-0001-5484-9390)
- Rafael Sanchez‐Salas (ORCID: https://orcid.org/0000-0002-7809-3580)
- Juán Casanova Ramón-Borja
- Jeremy Yuen‐Chun Teoh (ORCID: https://orcid.org/0000-0002-9361-2342)
- Chi‐Fai Ng (ORCID: https://orcid.org/0000-0002-1723-9646)
- Jean de la Rosette (ORCID: https://orcid.org/0000-0002-6308-1763)
- Kai Zhang (ORCID: https://orcid.org/0000-0002-5289-3619)
- José L. Domínguez-Escrig
- Éric Barret
- Julia Bohr
Institutions
- Chinese University of Hong Kong (HK)
- Beijing United Family Hospital (CN)
- Istanbul Medipol University (TR)
- Institute Mutualiste Montsouris (FR)
- Fundación Instituto Valenciano de Oncología (ES)
- Bashkir State Medical University (RU)
- Kliniken Essen-Mitte (DE)
- Amsterdam University Medical Centers (NL)
- King's College Hospital (GB)
- McGill University (CA)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1111/bju.16720
- Citations
- 5
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 7.59